Encore: Sepsis; Number One Preventable Cause of Death Worldwide

September 26, 2017
Hosted by Nancy C. Caralla

[Download MP3] [itunes] [Bookmark Episode]

Guest Information


[View Guest Page >]

[View Guest Page >]

Episode Description

In this episode Tex Kissoon, MD,a well-known doctor from Canada, will provide us with the insight into the global phenomenon of Sepsis. Sepsis affects more than 30 million lives per year yet it is almost unknown to the general public and is quite often misdiagnosed by medical professionals worldwide. The reasons of why that is with the "why" Sepsis is so deadly, and what you can do to increase Sepsis awareness-- will be discussed in the next 60 minutes. Dr. Kissoon is joined by Ray Schachter, a Sepsis survivor who has dedicated all of his available time to combating and raising awareness of Sepsis worldwide. Both are members of the Global Sepsis Alliance, which has established World Sepsis Day on September 13th every year to raise awareness for Sepsis worldwide.

C. diff. Spores and More

C. diff. Spores and More

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel

“C. diff. Spores and More” is an educational program providing you with up-to-date information pertaining to C. diff. and Healthcare-Associated infections. Raising awareness through education and advocacy saves lives worldwide. Topics are of C. difficile infection (CDI) prevention, treatments, and environmental safety products along with Healthcare-Associated Infection (HAI) awareness and more. Our guests are topic experts discussing Antibiotic Resistance, Research and Development, Clinical trials, Nutrition Counseling, Microbiome, Mental health, C. diff. survivors, and so much more. Please join us every Tuesday at 10 AM Pacific Time on the VoiceAmerica Health and Wellness Channel.

  • Snag
  • ecard
  • Bookmark and Share
Nancy C. Caralla

Nancy C. Caralla

Nancy C. Caralla, a three time C. diff. survivor, healthcare professional, and now dedicated to “Raising C. diff. Awareness” worldwide. Through the experiences is why we are so passionate raising C. diff. awareness. The C Diff Foundation was brought to fruition in November 2012 with a mission to educate and advocate for C. diff. infection prevention, treatment, and environmental safety worldwide. We now join the many successful hosts and programs on VoiceAmerica to deliver life-saving information through our program; “C. diff. Spores and More.”

  • Snag
  • ecard
  • Bookmark and Share

Episode Directory

October 2017

September 2017

  • 9/26/2017: Encore: Sepsis; Number One Preventable Cause of Death Worldwide Listen Now
  • 9/19/2017: C.diff. Hunger; Maintaing Proper Nutrition Listen Now
  • 9/12/2017: Encore: Managing C. difficile and other germs in Schools Listen Now
  • 9/5/2017: Managing C. difficile and other germs in Schools Listen Now

August 2017

Dr. Guy de Bruyn, MD

Dr. Guy de Bruyn is Director for Clinical Development at Sanofi Pasteur, overseeing a large phase III vaccine trial for the prevention of Clostridium difficile infection in some 19 countries on 5 continents around the world that started in the U.S. in 2013. Previously he was a program director for HIV prevention studies in South Africa. Dr. de Bruyn earned his medical degree from the University of the Witwatersrand, South Africa and his Master’s in Public Health from the University of Washington, USA, where he was a senior fellow in the Division of Allergy & Infectious Diseases. He is a member of the American College of Physicians and the Infectious Disease Society of America. View Guest page

Episode Listing:

Dr Christian Felter, MD

Dr. Christian Felter, MD is Associate VP, Global Medical Expert for Nosocomial Vaccines for Sanofi Pasteur based in Lyon, France. His focus is on their investigative Clostridium difficile vaccine. Dr. Felter has 11 years of experience in medical affairs roles in the US and Europe, covering therapeutic areas including Immunology, Rheumatology, and Infectious Diseases. Prior to Joining Sanofi Pasteur he was with Astellas Pharma, where he was Global Medical Affairs Director responsible for the Infectious Disease portfolio. He was responsible for the European medical strategy for the Fidaxomicin launch in 2011. Dr. Felter also served in roles with Merck Serono, Cubist Pharmaceuticals, and Wyeth in the UK and US. View Guest page

Episode Listing:

Deverick J. Anderson, MD, MPH, FIDSA, FSHEA


Dr. Dev Anderson is an Associate Professor in the Division of Infectious Diseases and Department of Medicine at Duke University Medical Center. He is currently Director of the Duke Center for Antimicrobial Stewardship and Infection Prevention, Co-Director of the Duke Infection Control Outreach Network, and Chair of the Antimicrobial Stewardship and Evaluation Team at Duke University Hospital.
Dr. Anderson completed an Internal Medicine Residency at Duke University Medical Center in 2004. He completed a fellowship in Infectious Diseases at Duke University Medical Center in 2006. He received a Master of Public Health in Epidemiology from the University of North Carolina School of Public Health in May of 2007. Dr. Anderson has authored over 135 peer-reviewed articles related to hospital-acquired infections, infection control, hospital epidemiology, antibiotic stewardship, and multidrug-resistant organisms. View Guest page

Episode Listing: